Aurovela Fe 1/20

Endometriosis, Low Testosterone, Osteoporosis + 16 more

Treatment

20 Active Studies for Aurovela Fe 1/20

Treatment for

Endometriosis

What is Aurovela Fe 1/20

NorethisteroneThe Generic name of this drug

Treatment SummaryNorethisterone (also known as norethindrone) is a type of synthetic hormone used to treat menstrual irregularities, endometriosis, and as part of contraceptive and hormone replacement therapy. It was first developed in 1951, but wasn't marketed for contraception until 1962. Norethisterone is a second-generation progestin that mimics the actions of natural progesterone, with greater potency.

Neconis the brand name

image of different drug pills on a surface

Aurovela Fe 1/20 Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Necon

Norethisterone

1967

347

Effectiveness

How Aurovela Fe 1/20 Affects PatientsNorethisterone is a type of pill taken by mouth that contains hormones. It is prescribed to help with contraception, or to treat hormone-related issues such as menopause or endometriosis. This medication works like the body's natural hormone progesterone, but is much more powerful. It helps to regulate the hormones in the body that are related to ovulation and other fertility factors. Taking norethisterone may slightly increase the risk of developing breast cancer. People taking this medication should be aware of this fact and perform regular breast self-exams to check for any lumps or masses.

How Aurovela Fe 1/20 works in the bodyNorethisterone works on target cells in the reproductive tract, breast, pituitary, hypothalamus, skeletal tissue and central nervous system. It increases the thickness of cervical mucus to stop sperm from entering the uterus and makes it difficult for a fertilized egg to implant. It also suppresses follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which prevents ovulation and corpus luteum development. When used as part of hormone replacement therapy, it prevents endometrial hyperplasia and lowers the risk of endometrial cancer in postmenopausal women. It also has a

When to interrupt dosage

The dosage of Aurovela Fe 1/20 is contingent upon the diagnosed condition, comprising Atrophic, Fracture and Hormone Replacement Therapy. The measure likewise fluctuates as per the technique of administration (e.g. Oral or Tablet) featured in the table beneath.

Condition

Dosage

Administration

Hot flashes

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormone Replacement Therapy

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Atrophic

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

female castration

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Low Testosterone

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

hypoestrogenism

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Therapeutic procedure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Fracture

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Ovarian Failure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Postmenopausal Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Vasomotor System

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Oral Contraceptives

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormonal Contraception

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Estrogen Deprivation Symptoms

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Menopause

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Birth Control

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Warnings

Aurovela Fe 1/20 has eight contraindications, so it should not be taken when enduring any of the conditions outlined in the table below.Aurovela Fe 1/20 Contraindications

Condition

Risk Level

Notes

active liver disease

Do Not Combine

Thrombophilia

Do Not Combine

Vaginal Hemorrhage

Do Not Combine

Malignant Neoplasms

Do Not Combine

Benign hepatic neoplasm

Do Not Combine

Breast Cancer

Do Not Combine

Thromboembolism

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Norethisterone may interact with Pulse Frequency

There are 20 known major drug interactions with Aurovela Fe 1/20.

Common Aurovela Fe 1/20 Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Norethisterone.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Norethisterone.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Norethisterone.

Clomipramine

Major

The metabolism of Clomipramine can be increased when combined with Norethisterone.

Copanlisib

Major

The metabolism of Copanlisib can be decreased when combined with Norethisterone.

Aurovela Fe 1/20 Toxicity & Overdose RiskThe lowest toxic dose of oral contraceptives in mice is 6 g/kg and 42 mg/kg in women. So far, there have been no reports of serious consequences following an overdose of oral contraceptives, even if taken by children. However, symptoms of overdosage may include nausea and/or vomiting.

image of a doctor in a lab doing drug, clinical research

Aurovela Fe 1/20 Novel Uses: Which Conditions Have a Clinical Trial Featuring Aurovela Fe 1/20?

160 active studies are currently examining the efficacy of Aurovela Fe 1/20 for Birth Control, Atrophic Conditions and Low Testosterone Levels.

Condition

Clinical Trials

Trial Phases

Birth Control

31 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Early Phase 1

Estrogen Deprivation Symptoms

0 Actively Recruiting

Hot flashes

22 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1

Endometriosis

32 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 4, Phase 1

Oral Contraceptives

2 Actively Recruiting

Not Applicable

Osteoporosis

40 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4, Phase 3

Therapeutic procedure

0 Actively Recruiting

Low Testosterone

15 Actively Recruiting

Phase 1, Phase 4, Phase 2, Not Applicable

Menopause

0 Actively Recruiting

Hormone Replacement Therapy

0 Actively Recruiting

Atrophic

5 Actively Recruiting

Phase 2, Phase 4, Not Applicable

Postmenopausal Osteoporosis

3 Actively Recruiting

Not Applicable, Phase 4

Fracture

0 Actively Recruiting

female castration

0 Actively Recruiting

hypoestrogenism

2 Actively Recruiting

Phase 4

Vasomotor System

0 Actively Recruiting

Endometriosis

1 Actively Recruiting

Phase 4

Ovarian Failure

2 Actively Recruiting

Not Applicable, Phase 1

Hormonal Contraception

0 Actively Recruiting

Aurovela Fe 1/20 Reviews: What are patients saying about Aurovela Fe 1/20?

3.3Patient Review

2/12/2022

Aurovela Fe 1/20 for Endometriosis

If you're an hour late taking the medication, you will start your period.

2.7Patient Review

8/6/2021

Aurovela Fe 1/20 for Birth Control

I unfortunately gained a lot of weight while on this pill; however, it did make my periods lighter and shorter.

1.3Patient Review

5/8/2022

Aurovela Fe 1/20 for Birth Control

I became incredibly anxious and depressed after taking this medication, to the point where I started having suicidal thoughts. It was honestly the worst experience of my life and I would never recommend it to anyone.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about aurovela fe 1/20

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Aurovela Fe 1/20 prevent pregnancy?

"Aurovela Fe 1/20 is a product that helps to prevent pregnancy in women. It is indicated for use by women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective."

Answered by AI

What is the generic name for Aurovela Fe 1 20?

"Aurovela Fe 1 / 20 is a combination of ethinyl estradiol and norethindrone. It is used as an contraception to prevent pregnancy."

Answered by AI

What are the side effects of Aurovela Fe 1 20?

"Side effects may include nausea, vomiting, headache, bloating, breast tenderness, fluid retention, or weight change. Spotting or missed/irregular periods may occur, especially during the first few months of use."

Answered by AI

What kind of birth control is Aurovela 1 20?

"This medication contains a combination of two hormones, progestin and estrogen, which are used to prevent pregnancy. In addition to preventing pregnancy, birth control pills can also make your periods more regular, decrease blood loss and pain during periods, and decrease your risk of developing ovarian cysts. This medication can also be used to treat acne."

Answered by AI

Clinical Trials for Aurovela Fe 1/20

Image of University of Colorado Department of Obstetrics & Gynecology in Aurora, United States.

Elagolix for Infertility

This trial is testing a new medication given by mouth to women with endometriosis who are trying to get pregnant through IVF. The main goal is to see if the medication can increase the chances

University of Colorado Department of Obstetrics & Gynecology (+4 Sites)Hugh Taylor, MD

Image of University of Michigan in Ann Arbor, United States.

My Pelvic Plan Website for Endometriosis

This trial aims to see if an online self-management program can help patients with Chronic Pelvic Pain feel better. The researchers believe that patients using the program will have less pain, better physical function, and

Waitlist Available

University of MichiganSara Till, MD

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Desogestrel / Ethinyl Estradiol Pill for Birth Control

This trial aims to understand how differences in our DNA can affect how our bodies process hormones in birth control pills, potentially influencing their effectiveness in preventing pregnancy and causing different side effects in individuals. Participants will take

Waitlist Available

University of Colorado Anschutz Medical Campus (+1 Sites)Aaron M Lazorwitz, MD, PhD

Image of McLean Function Measurement Lab in Ottawa, Canada.

Repetitive Transcranial Magnetic Stimulation for Endometriosis

This trial aims to improve pain outcomes for Canadian women with endometriosis. It will test the effectiveness of a repetitive transcranial magnetic stimulation (rTMS) intervention for reducing pain in individuals

No Prior Treatment

McLean Function Measurement LabLinda McLean, PhD

Have you considered Aurovela Fe 1/20 clinical trials? We made a collection of clinical trials featuring Aurovela Fe 1/20, we think they might fit your search criteria.

Explore trials for Aurovela Fe 1/20

Image of University of Central Florida in Orlando, United States.

Wrist/hand immobilization for Menstruation

"This trial aims to understand why females tend to get more hand and wrist injuries compared to males in sports. The study will look at the impact of hormones, such as those from birth control, on muscle

University of Central Florida

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Transdermal Estradiol Patch +2 More for Menopause

"This trial aims to study how the decrease in estrogen during menopause affects artery health and body fat distribution in women. The researchers will investigate whether low estrogen levels lead to decreased artery function and increased fat in

Waitlist Available

University of Colorado Anschutz Medical CampusKerrie Moreau, PhD

Image of University of Kentucky in Lexington, United States.

Alendronate for Osteoporosis

This trial aims to address the issue of age-related bone loss, which is often overlooked in current osteoporosis treatments. The study compares the effectiveness of two drugs, Alendronate and Terip

Waitlist Available

University of KentuckyHartmut H Malluche, MD

Image of Hybl Sports Medicine and Performance Center in Colorado Springs, United States.

Hot Water Therapy for Menopause

Colorado Springs, CO

This trial is studying the effects of hot water therapy on menopausal women. The researchers want to see if taking hot baths for multiple days in a row can reduce hot flash symptoms and improve mood.

Hybl Sports Medicine and Performance CenterNathan Morris, PhD

Have you considered Aurovela Fe 1/20 clinical trials? We made a collection of clinical trials featuring Aurovela Fe 1/20, we think they might fit your search criteria.

Explore trials for Aurovela Fe 1/20

Image of University of Arizona in Tucson, United States.

PhytoSERM for Hot Flashes

This trial is testing the effects of a supplement called PhytoSERM on menopausal symptoms in women. Participants will either take PhytoSERM pills or a placebo for 12 weeks. After

University of ArizonaFei Yin, PhDNeuTherapeutics

Image of Citruslabs in Santa Monica, United States.

Probiotic Supplement for Menopause Symptoms

Santa Monica, CA

This trial tests if a probiotic supplement can reduce menopause symptoms like hot flashes, night sweats, mood swings, etc. Participants take a test product or placebo daily and provide data on weight, waist, sleep, and symptoms.

Waitlist Available

Dietary Supplement

CitruslabsManeuver Marketing

Image of Planned Parenthood of Northern California in Berkeley, United States.

Ovaprene for Birth Control

This trial will study a new, non-hormonal contraceptive ring for safety, effectiveness, and acceptability.

Planned Parenthood of Northern California (+20 Sites)Christine Mauck, MDDaré Bioscience, Inc.

Image of St. Barnabas Woodlands in Pittsburgh, United States.

Denosumab +1 More for Osteoporosis

This trial aims to show that a new medication called Denosumab can help older adults who are weak and frail by improving their muscle health, strength, mobility, and overall function.

St. Barnabas Woodlands

Have you considered Aurovela Fe 1/20 clinical trials? We made a collection of clinical trials featuring Aurovela Fe 1/20, we think they might fit your search criteria.

Explore trials for Aurovela Fe 1/20

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security